SCHEMBL19102198

SCHEMBL19102198

CN(C)[C@@H]1CCN(Cc2cccc(-c3cnc(N)c(C(=O)Nc4ccccc4)n3)c2)C1

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 20/20 0.72
▸ PRKDC P78527 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19102095 0.88 ATR (0.70) ATRPRKDC
SCHEMBL19102194 0.85 ATR (0.73) ATRPRKDC
SCHEMBL19102163 0.84 ATR (0.77) ATRPRKDC
SCHEMBL13138646 0.84 ATR (1.00) ATR
SCHEMBL2484696 0.84 ATR (1.00) ATR
SCHEMBL19102144 0.84 ATR (0.73) ATRPRKDC
SCHEMBL16424874 0.78 ATR (1.00) ATRPRKDC
SCHEMBL13138597 0.78 ATR (1.00) ATRPRKDC
SCHEMBL2486916 0.78 ATR (1.00) ATRPRKDC
SCHEMBL31388063 0.78 ATR (0.60) ATRPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701674-B2 Substituted pyrazines as ATR kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-11 — — US disclosed
Send feedback